RSRache M. Simmons

Rache M. Simmons

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rache M. Simmons has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072

    by on behalf of the ACOSOG investigators, Rache M. Simmons, Karla V. Ballman, Charles Cox, Ned Carp, Jennifer Sabol, Rosa F. Hwang, Deanna Attai, Michael Sabel, David Nathanson, et al.

    Cryoablation is a well-established technique to treat fibroadenomas. Pilot studies suggest this could be an effective non-surgical treatment for breast can


  • Mastectomy for Invasive Breast Cancer

    by Tracy-Ann Moo, Rache M. Simmons

  • The Evaluation and Treatment of Nipple Discharge

    by Meredith Kato, Rache M. Simmons

  • Sentinel Node Positivity Rates With and Without Frozen Section for Breast Cancer

    by Nimmi Arora, Diana Martins, Tara L. Huston, Paul Christos, Syed Hoda, Michael P. Osborne, Alexander J. Swistel, Eleni Tousimis, Peter I. Pressman, Rache M. Simmons

    Sentinel lymph node biopsy (SLNB) is used to detect breast cancer axillary metastases. Some surgeons send the sentinel lymph node (SLN) for intraoperative frozen section (FS) to minimize delayed axillary dissections. There has been concern that FS may discard nodal tissue and thus underdiagnose small metastases. This study examines whether evaluation of SLN by FS increases the false-negative rate of SLNB. A retrospective analysis of SLNB from 659 patients was conducted to determine the frequency of node positivity among SLNB subjected to both FS and permanent section (PS) versus PS alone. Statistical analysis was performed by the χ2 square test, and a logistic regression model was applied to estimate the effect of final node positivity between the two groups. FS was performed in 327 patients and PS was performed in all 659 patients. Among patients undergoing both FS and PS (n = 327), the final node positivity rate was 33.0% compared with 19.6% among patients undergoing PS alone (n = 332). After adjustment for patient age, tumor diameter, grade, and hormone receptor status in a multivariate logistic regression model, there remained an increased likelihood of final node positivity for patients undergoing both procedures relative to PS alone (adjusted odds ratio, 2.1; 95% confidence interval, 1.3–3.6; P = .005). There was a higher rate of SLN positivity in specimens evaluated by both FS and PS. Therefore, evaluating SLN by FS does not underdiagnose small metastases nor produce a higher false-negative rate. Intraoperative FS offers the advantage of less delayed axillary dissections.


  • Open Access

    Minimally invasive approaches: cryoablation

    by T. L. Huston, R. M. Simmons

    As widespread screening for breast cancer detects more women at younger ages and earlier stages, the need for minimally invasive, cosmetically preferable approaches to its treatment grows. The combination of a superficial location on the thorax and lack of intervening organs makes the breast ideal for ablative therapies, one of which is cryoablation. Cryoablation destroys tissue through multiple cycles of localized freezing. Major advantages to cryoablation are: the ability to perform the procedure in the office under real-time ultrasound guidance, improved post-procedure cosmesis when compared to breast conserving surgery since only a 2 mm skin incision is necessary, and the avoidance of anesthesia since freezing numbs the breast. Numerous studies, reviewed here, have demonstrated success in eradication of invasive breast cancer using this modality. However, before cryoablation can be added to the armamentarium of those who treat breast cancer, prospective randomized trials are needed to determine its long-term effectiveness.


  • Factors Associated With Residual Breast Cancer After Re-excision for Close or Positive Margins

    by C. Cellini, S. T. Hollenbeck, P. Christos, D. Martins, J. Carson, S. Kemper, E. LaVigne, E. Chan, R. Simmons

    Background: Successful breast conservation surgery (BCS) requires complete tumor excision. Margin status of the initial specimen determines the need for additional surgery. We explored factors associated with residual cancer (RC) upon follow-up surgery in patients with close, positive, or undetermined margins following BCS. Methods: A retrospective analysis of 276 patients with initial close, positive, or undetermined margins who underwent re-excision (RE) or mastectomy was conducted. All initial excisions were intended as definitive procedures. Chi-square analysis was used to identify factors that may predict RC. Results: Of 276 patients, 87 had close, 168 had positive, and 21 had undetermined margins on initial excision. Of this group, 63% (175/276) had RC upon RE or mastectomy. Of positive-margin patients, 68% had RC, compared with 53% of close-margin and 67% of undetermined-margin patients (P = .006). Tumors ≥2 cm were more often associated with RC than smaller tumors (70.8% vs. 56.5%; P = .07). This association was strongest in positive-margin patients (P = .04). High tumor grade was associated with RC in all groups. RC linearly increased with the number of involved margins (P = .02). Specimen inking with multiple colors was associated with decreased risk of RC (P = .004). Conclusions: Over half of patients with involved or undetermined margins had RC upon RE or mastectomy. Positive and undetermined margins were more often associated with RC than close margins. Larger tumor size was associated with RC in patients with positive. Increasing tumor grade suggests a greater chance of detecting RC in all groups. Multiple involved margins led to a greater risk of RC.


  • Two-year follow-up of areola-sparing mastectomy with immediate reconstruction

    by Rache M. Simmons, Scott T. Hollenbeck, Gregory S. LaTrenta


  • Ductal Carcinoma in Situ in a 27-Year-Old Woman with McCune-Albright Syndrome

    by Tara L. Huston, Rache M. Simmons

    McCune-Albright syndrome (MAS) is a sporadic disorder characterized by the triad of irregularly edged hyperpigmented macules (café au lait spots); a slowly progressive bone disorder, polyostotic fibrous dysplasia, usually involving the base of the skull and the long bones; and luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty. This case is the first report of a 27-year-old woman with ductal carcinoma in situ (DCIS) and Paget's disease of the nipple associated with MAS. The discussion focuses on two endocrine manifestations of this syndrome including precocious puberty and excess growth hormone secretion. In our patient, both her early puberty and pituitary adenoma, in association with MAS, resulted in excess production and secretion of estrogen and growth hormone. Both of these hormones function to stimulate breast growth and development. We hypothesize they are responsible for this patient's DCIS and Paget's disease of the nipple so early in life.


  • Breast cancer in patients with residual invasive carcinoma is more accurately staged with additive tumor size assessment.

    by S. T. Hollenbeck, C. Cellini, P. Christos, Y. Varnado-Rhodes, D. Martins, M. Nussbaum, M. P. Osborne, R. M. Simmons


  • Areola-Sparing Mastectomy With Immediate Breast Reconstruction

    by Rache M. Simmons, Scott T. Hollenbeck, Gregory S. Latrenta

    Skin-sparing mastectomy with immediate breast reconstruction is a proved option for patients with early-stage breast cancer requiring mastectomy. Based on the authors’ recent pathologic analysis of mastectomy specimens showing less than 1% malignant involvement of the areola, they have begun to perform areola-sparing mastectomies (ASMs) on a select group of patients. They report their results from an ongoing study of ASM at their institution. During a 20-month period, 17 ASMs with immediate reconstruction were performed on 12 patients. Mastectomy was performed for breast cancer prophylaxis (n = 10), ductal carcinoma in situ (n = 4), and less than 2 cm of peripheral infiltrating carcinoma (n = 3). The most frequent incision performed was intraareola (n = 13). Thirteen patients were reconstructed with tissue expanders and 4 with pedicled transverse rectus abdominis musculocutaneous flaps. There was 1 postoperative complication, which consisted of a localized wound infection. Overall the authors found that ASM with immediate reconstruction provides excellent aesthetic results with infrequent complications.